Gyon Technologies Capital Management, LP Catalyst Biosciences, Inc. Transaction History

Gyon Technologies Capital Management, LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.36 - $1.78 $8,431 - $41,689	-23,421 Closed	0 $0
Q1 2022 May 12, 2022	SELL	$0.51 - $1.0 $67,895 - $133,129	-133,129 Reduced 85.04%	23,421 $15,000
Q4 2021 Feb 11, 2022	BUY	$0.91 - $4.16 $142,460 - $651,248	156,550 New	156,550 $143,000

215

Ticker CBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,477,100
Description
Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. The company's protease engineering platform creates improved or novel molecules to treat diseases that result from dysregulation of the complement system. It develops CB ...

Get notified when there are updates to the investment portfolio of Gyon Technologies Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Gyon Technologies Capital Management, LP with notifications on news.